This is a non-core endpoint: only basic statistics are computed.
Other benign neoplasms of skin (controls excluding all cancers)
CD2_BENIGN_SKIN_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints
-
Remove individuals based on genotype QC
13521
CD2_BENIGN_SKIN_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Alia neoplasmata benigna cutis
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Other benign neoplasms of skin (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Other benign neoplasms of skin
- Benign neoplasms
- Benign neoplasms (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Narrower endpoints:
- Other benign neoplasms of skin
- Benign neoplasm: Skin of eyelid, including canthus (controls excluding all cancers)
- Benign neoplasm: Skin of eyelid, including canthus
- Benign neoplasm: Skin of other and unspecified parts of face
- Benign neoplasm: Skin of other and unspecified parts of face (controls excluding all cancers)
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13521 | 7978 | 5543 |
| Unadjusted prevalence (%) | 3.28 | 3.47 | 3.05 |
| Mean age at first event (years) | 55.08 | 52.55 | 58.74 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_SKIN_EXALLC – Other benign neoplasms of skin (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other benign neoplasms of skin (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.